Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9461415, 9 pages
https://doi.org/10.1155/2017/9461415
Review Article

The Characteristics of TCM Clinical Trials: A Systematic Review of ClinicalTrials.gov

1Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2Medical Science & Computing, LLC, Rockville, MD 20852, USA

Correspondence should be addressed to Qingshan Zheng; ten.anihcgurd@gnehz.nahsgniq

Received 7 February 2017; Accepted 24 July 2017; Published 24 August 2017

Academic Editor: Bhushan Patwardhan

Copyright © 2017 Junchao Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. T. Cheng, “Review: drug therapy in Chinese traditional medicine,” Journal of Clinical Pharmacology, vol. 40, no. 5, pp. 445–450, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Chen, Y. M. Zhang, Q. H. Zheng, and K. Z. Wang, “Analysis on Current Situation of acupuncture,” Liaoning Zhong Yi Yao Da Xue Xue Bao, vol. 10, no. 7, pp. 19–21, 2008. View at Google Scholar
  3. G. S. Birdee, P. M. Wayne, R. B. Davis, R. S. Phillips, and G. Y. Yeh, “T'ai Chi and Qigong for health: patterns of use in the United States,” Journal of Alternative and Complementary Medicine, vol. 15, no. 9, pp. 969–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Akobeng, “Understanding randomised controlled trials,” Archives of Disease in Childhood, vol. 90, no. 8, pp. 840–844, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Pan, M. Wang, H. Song, L. Wang, and G. Ji, “The efficacy and safety of Traditional Chinese Medicine (Jiang Zhi Granule) for nonalcoholic fatty liver: a multicenter, randomized, placebo-controlled study,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 965723, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Shang, J. Zhang, C. Yao et al., “Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 738391, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Sawynok and M. Lynch, “Qigong and fibromyalgia: randomized controlled trials and beyond,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 379715, 14 pages, 2014. View at Publisher · View at Google Scholar
  8. Y. Yan, W. Liu, P. Andres et al., “Exploratory clinical trial to evaluate the efficacy of a topical traditional Chinese herbal medicine in psoriasis vulgaris,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 719641, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. D. DeAngelis, J. M. Drazen, F. A. Frizelle et al., “Clinical trial registration: A statement from the International Committee of Medical Journal Editors,” Journal of the American Medical Association, vol. 292, no. 11, pp. 1363-1364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Zarin and A. Keselman, “Registering a clinical trial in ClinicalTrial.gov,” Chest, vol. 131, no. 3, pp. 909–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Tasneem, L. Aberle, H. Ananth et al., “The database for aggregate analysis of Clinicaltrials.gov (AACT) and subsequent regrouping by clinical specialty,” PLoS ONE, vol. 7, no. 3, Article ID e33677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Anderson, K. Chiswell, E. D. Peterson, A. Tasneem, J. Topping, and R. M. Califf, “Compliance with results reporting at ClinicalTrials.gov,” New England Journal of Medicine, vol. 372, no. 11, pp. 1031–1039, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. “ClinicalTrials.gov. Protocol Data Element Definitions,” 2015, https://prsinfo.clinicaltrials.gov/definitions.html.
  14. D. A. Zarin, T. Tse, R. J. Williams, R. M. Califf, and N. C. Ide, “The ClinicalTrials.gov results database - Update and key issues,” New England Journal of Medicine, vol. 364, no. 9, pp. 852–860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. “International statistical classification of diseases and related health problems 10th revision database,” 2016, http://apps.who.int/classifications/icd10/browse/2010/en.
  16. J. K. Inrig, R. M. Califf, A. Tasneem et al., “The landscape of clinical trials in nephrology: A systematic review of clinicaltrials.gov,” American Journal of Kidney Diseases, vol. 63, no. 5, pp. 771–780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. A. P. Prayle, M. N. Hurley, and A. R. Smyth, “Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: Cross sectional study,” BMJ (Online), vol. 344, no. 7838, Article ID d7373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. W. Chan, J. M. Tetzlaff, D. G. Altman et al., “SPIRIT 2013 statement: defining standard protocol items for clinical trials,” Annals of Internal Medicine, vol. 158, no. 3, pp. 200–207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Qi, A. Li, Y. Inagaki et al., “Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer,” Bioscience Trends, vol. 4, no. 6, pp. 297–307, 2010. View at Google Scholar
  20. C.-Z. Wang, T. Calway, and C.-S. Yuan, “Herbal medicines as adjuvants for cancer therapeutics,” American Journal of Chinese Medicine, vol. 40, no. 4, pp. 657–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. I. Lu and D. P. Lu, “Impact of chinese herbal medicine on american society and health care system: perspective and concern,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 251891, 6 pages, 2014. View at Publisher · View at Google Scholar
  22. S. K. Pasquali, W. K. Lam, K. Chiswell, A. R. Kemper, and J. S. Li, “Status of the pediatric clinical trials enterprise: An analysis of the US ClinicalTrials.gov registry,” Pediatrics, vol. 130, no. 5, pp. e1269–e1277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-Y. Fu, “Current status of research on complementary and alternative medicine in the United States: In comparison with that on traditional Chinese medicine in China,” Journal of Chinese Integrative Medicine, vol. 6, no. 6, pp. 551–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Li, “Joint statement of establishing Chinese Clinical Trial registration and publishing system,” Journal of Chinese Integrative Medicine, vol. 4, no. 4, pp. 331-332, 2006. View at Publisher · View at Google Scholar